Evidence supporting the use of: Bromelain
For the health condition: Allergies (respiratory)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bromelain, an enzyme extract derived from pineapples, has been explored for its potential benefits in managing respiratory allergies, particularly due to its anti-inflammatory and mucolytic properties. Scientific investigations, predominantly in vitro and in animal models, suggest that bromelain may reduce nasal mucosal inflammation and modulate immune responses by decreasing levels of pro-inflammatory cytokines such as IL-4, IL-13, and TNF-alpha. Some small human studies and case reports have indicated improvements in symptoms of allergic rhinitis, such as nasal congestion and sinusitis, when bromelain is used as an adjunct therapy.

Despite these promising findings, the clinical evidence remains limited and of low quality. Randomized controlled trials in humans are scarce, with most studies involving small sample sizes or lacking rigorous controls. Consequently, systematic reviews and meta-analyses have generally concluded that while bromelain appears safe and may provide some symptomatic relief for respiratory allergies, there is insufficient high-quality evidence to make firm recommendations for its widespread use in this context.

In summary, bromelain shows potential as a supportive agent for respiratory allergies based on preliminary scientific research, but more robust clinical trials are needed to confirm its efficacy and optimal dosing. Its use is supported more by emerging scientific investigation than by strong traditional or large-scale clinical validation.

More about bromelain
More about Allergies (respiratory)